Age-Related Success with Elective Single versus Double Blastocyst Transfer

Friedman, Bruce J.; Davis, L.B.; Lathi, Ruth B.; Westphal, Lynn M.; Baker, Valerie L.; Milki, Amin A.

doi:10.5402/2011/656204

Cited by 4 publications

(1 citation statement)

References 32 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of multiple pregnancies is related to pre-term birth, birth of babies with low weight and other complications, and risks to mothers and babies ( Fauser et al, 2005 ; Vulliemoz et al, 2012 ). The high incidence of multiple pregnancies when using ART is related to the fact that sometimes more than one embryo is transferred into the female reproductive tract ( Friedman et al, 2011 ; Mersereau et al, 2017 ).…”

Section: Multiple Pregnancymentioning

confidence: 99%

The Potential of Nanotechnology in Medically Assisted Reproduction

et al. 2018

View full text Add to dashboard Cite

Reproductive medicine is a field of science which searches for new alternatives not only to help couples achieve pregnancy and preserve fertility, but also to diagnose and treat diseases which can impair the normal operation of the reproductive tract. Assisted reproductive technology (ART) is a set of methodologies applied to cases related to infertility. Despite being highly practiced worldwide, ART presents some challenges, which still require special attention. Nanotechnology, as a tool for reproductive medicine, has been considered to help overcome some of those impairments. Over recent years, nanotechnology approaches applied to reproductive medicine have provided strategies to improve diagnosis and increase specificity and sensitivity. For in vitro embryo production, studies in non-human models have been used to deliver molecules to gametes and embryos. The exploration of nanotechnology for ART would bring great advances. In this way, experiments in non-human models to test the development and safety of new protocols using nanomaterials are very important for informing potential future employment in humans. This paper presents recent developments in nanotechnology regarding impairments still faced by ART: ovary stimulation, multiple pregnancy, and genetic disorders. New perspectives for further use of nanotechnology in reproductive medicine studies are also discussed.

show abstract

Section: Multiple Pregnancymentioning

confidence: 99%

The Potential of Nanotechnology in Medically Assisted Reproduction

et al. 2018

View full text Add to dashboard Cite

show abstract

Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients

Knez

Kovačič

Vlaisavljević

2013

Reproductive BioMedicine Online

View full text Add to dashboard Cite

A reduction in the number of embryos transferred is the most important step in decreasing multiple gestation rates after medically assisted reproduction. Slovenia has implemented insurance company regulations that regulate single-embryo transfer in selected good-prognosis couples. The aim of the present study was to evaluate its effects on the Slovenian population compared with cross-border patients, who are not affected by the insurance company policy. Ultimately, 2403 couples undergoing IVF or intracytoplasmic sperm injection were included in the retrospective analysis. Patients were classified according to their origin. The decision about the number of embryos transferred and the treatment success were evaluated. The implementation of the policy favouring single-embryo transfer resulted in a significant decrease in the twin birth rate in Slovenian patients (24.4% before policy versus 6.7% after policy implementation, P<0.001). Although in cross-border patients twin birth rates have declined through the study period, they remained significantly higher compared with Slovenian patients (23.1% versus 6.7%, P<0.001). The data demonstrate that insurance company policies favouring single-embryo transfer are an effective tool in decreasing multiple gestation rates. Similar mechanisms should be implemented in the cross-border patient population.

show abstract

Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta-analysis

Peng

et al. 2022

Reprod Biol Endocrinol

View full text Add to dashboard Cite

Background Evidence referring to the trade-offs between the benefits and risks of single embryo transfer (SET) versus double embryo transfer (DET) following assisted reproduction technology are insufficient, especially for those women with a defined embryo quality or advanced age. Methods A systematic review and meta-analysis was conducted according to PRISMA guidelines. PubMed, EMBASE, Cochrane Library and ClinicalTrials.gov were searched based on established search strategy from inception through February 2021. Pre-specified primary outcomes were live birth rate (LBR) and multiple pregnancy rate (MPR). Odds ratio (OR) with 95% confidence interval (CI) were pooled by a random-effects model using R version 4.1.0. Results Eighty-five studies (14 randomized controlled trials and 71 observational studies) were eligible. Compared with DET, SET decreased the probability of a live birth (OR = 0.78, 95% CI: 0.71–0.85, P < 0.001, n = 62), and lowered the rate of multiple pregnancy (0.05, 0.04–0.06, P < 0.001, n = 45). In the sub-analyses of age stratification, both the differences of LBR (0.87, 0.54–1.40, P = 0.565, n = 4) and MPR (0.34, 0.06–2.03, P = 0.236, n = 3) between SET and DET groups became insignificant in patients aged ≥40 years. No significant difference in LBR for single GQE versus two embryos of mixed quality [GQE + PQE (non-good quality embryo)] (0.99, 0.77–1.27, P = 0.915, n = 8), nor any difference of MPR in single PQE versus two PQEs (0.23, 0.04–1.49, P = 0.123, n = 6). Moreover, women who conceived through SET were associated with lower risks of poor outcomes, including cesarean section (0.64, 0.43-0.94), antepartum haemorrhage (0.35, 0.15-0.82), preterm birth (0.25, 0.21-0.30), low birth weight (0.20, 0.16-0.25), Apgar1 < 7 rate (0.12, 0.02-0.93) or neonatal intensive care unit admission (0.30, 0.14-0.66) than those following DET. Conclusions In women aged < 40 years or if any GQE is available, SET should be incorporated into clinical practice. While in the absence of GQEs, DET may be preferable. However, for elderly women aged ≥40 years, current evidence is not enough to recommend an appropriate number of embryo transfer. The findings need to be further confirmed.

show abstract

Age-Related Success with Elective Single versus Double Blastocyst Transfer

Cited by 4 publications

References 32 publications

The Potential of Nanotechnology in Medically Assisted Reproduction

The Potential of Nanotechnology in Medically Assisted Reproduction

Comparison of embryo transfer strategies and assisted reproduction outcome in Slovenian and cross-border patients

Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta-analysis

Contact Info

Product

Resources

About